Detalhe da pesquisa
1.
Heterologous booster with a novel formulation containing glycosylated trimeric S protein is effective against Omicron.
Front Immunol
; 14: 1271209, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-38022542
2.
Immunological study of COVID-19 vaccine candidate based on recombinant spike trimer protein from different SARS-CoV-2 variants of concern.
Front Immunol
; 13: 1020159, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36248791